经PulseRider部署Enterprise支架治疗前交通动脉动脉瘤复发
本文报告一例55岁男性,前交通动脉8 mm动脉瘤经PulseRider辅助弹簧圈栓塞后6个月数字减影血管造影显示复发,遂在A1-A2段跨过既往置入的PulseRider部署Enterprise 2闭环支架,支架正确展开并完成动脉瘤充分栓塞,结论认为经PulseRider可安全打开Enterprise支架以治疗动脉瘤复发。
要点
- 55岁男性前交通动脉8 mm动脉瘤经PulseRider辅助栓塞后6个月造影示复发。
- 在A1-A2段跨过既往PulseRider部署Enterprise 2闭环支架,支架正确展开。
- 支架展开后完成动脉瘤充分栓塞,作者认为经PulseRider可安全打开Enterprise支架。
核心结论
- 作者认为经PulseRider可安全打开Enterprise支架以治疗动脉瘤复发。
研究设计与样本
- 病例报告:1例55岁男性前交通动脉8 mm动脉瘤患者。
主要发现
- 患者先前接受PulseRider颈部重建装置辅助的动脉瘤弹簧圈栓塞。
- 6个月数字减影血管造影控制显示动脉瘤复发。
- 在A1-A2段跨过既往置入的PulseRider部署Enterprise 2闭环支架,支架正确展开并完成动脉瘤充分栓塞。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: PulseRider (Pulsar Vascular, Los Gatos, California, USA) is a new endovascular device designed to treat wide-neck bifurcation intracranial aneurysms. Deployment of a stent through a PulseRider to treat an aneurysm's recurrence has never been described before. CASE DESCRIPTION: We report the case of a 55-year-old man who underwent coiling of an 8-mm anterior communicating artery aneurysm with assistance of a PulseRider neck reconstruction device. The 6-month digital subtraction angiography control showed aneurysm recurrence, so we deployed an Enterprise 2 closed-cell stent (Codman, Miami Lakes, Florida, USA) in the A1-A2 segment passing across the previously implanted PulseRider. Enterprise correctly expanded and allowed for adequate coiling of the aneurysm. CONCLUSION: An Enterprise stent can be safely opened through a PulseRider in order to treat aneurysm recurrence.
引用
- Valente I, Limbucci N, Nappini S, et al. Enterprise Deployment Through PulseRider To Treat Anterior Communicating Artery Aneurysm Recurrence. World Neurosurg. 2017. PMID: 29155064. doi:10.1016/j.wneu.2017.11.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。